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ABSTRACT
Exposure to endocrine disrupting chemicals is an established risk factor for obesity. The most commonly used pesticide
active ingredients have never been tested in an adipogenesis assay. We tested for the first time the potential of glyphosate,
2, 4-dichlorophenoxyacetic acid, dicamba, mesotrione, isoxaflutole, and quizalofop-p-ethyl (QpE) to induce lipid
accumulation in murine 3T3-L1 adipocytes. Only QpE caused a dose-dependent statistically significant triglyceride
accumulation from a concentration of 5 up to 100 mM. The QpE commercial formulation Targa Super was 100 times more
cytotoxic than QpE alone. Neither the estrogen receptor antagonist ICI 182, 780 nor the glucocorticoid receptor antagonist
RU486 was able to block the QpE-induced lipid accumulation. RNAseq analysis of 3T3-L1 adipocytes exposed to QpE
suggests that this compound exerts its lipid accumulation effects via a peroxisome proliferator-activated receptor gamma
(PPARc)-mediated pathway, a nuclear receptor whose modulation influences lipid metabolism. QpE was further shown to
be active in a PPARc reporter gene assay at 100 mM, reaching 4% of the maximal response produced by rosiglitazone, which
acts as a positive control. This indicates that lipid accumulation induced by QpE is only in part caused by PPARc activation.
The lipid accumulation capability of QpE we observe suggest that this pesticide, whose use is likely to increase in coming
years may have a hitherto unsuspected obesogenic property.
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Obesity has become a global health problem over the past 30
years (Collaboration, 2017). The worldwide prevalence of obesity
has tripled since 1975 and it is estimated that 39% of the global
adult population is overweight (BMI 25) and 13% obese (BMI 
30). The most dramatic increase has been reported in children
and adolescents of 5–19 years of age, where the incidence of
obesity has risen from 4% to 18% between 1975 and 2016
(Collaboration, 2017). Obesity is a complex and multifactorial
condition with both genetic and behavioral causative compo-
nents (Ghosh and Bouchard, 2017). Exposure to environmental
pollutants and toxicants is now recognized to be a risk factor for
obesity (Newbold, 2010). Among the environmental factors pre-
disposing to obesity, there has been increasing interest in the
role of endocrine disruptive chemicals (EDCs) such as pesticides
(Thayer et al., 2012).
EDCs promote adipogenesis and induce obesity by altering lipid
metabolic pathways, deregulating adipogenesis and energy bal-
ance, or promoting lipid accumulation in adipocytes (Janesick and
Blumberg, 2016). A large number of in vitro studies have shown
that some xenobiotics, such as tributyltin chloride and bisphenol
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A, can promote adipocyte differentiation (Chamorro-Garcia et al.,
2012; Li et al., 2011). Furthermore, in vivo animal studies and human
epidemiological investigations have linked exposure to certain
chemicals to an increased fat deposition and consequently an in-
crease in body weight (Grun et al., 2006; Janesick and Blumberg,
2011). Of even greater concern is the fact that prenatal or early life
exposure to environmental obesogens can predispose individuals
to an increased probability to develop obesity in adult life (Janesick
and Blumberg, 2011). A predisposition to obesity and some associ-
ated diseases such as nonalcoholic fatty liver disease can also be
transmitted transgenerationally via epigenetic mechanisms
(Chamorro-Garcia et al., 2013).
An increasing number of studies report the association be-
tween the use of pesticides and the onset of obesity
(Rosenbaum et al., 2017; Vassilopoulou et al., 2017). The exten-
sive use of pesticides in an agricultural setting leads to the con-
sumption of foodstuffs contaminated by pesticide residues
(Damalas and Eleftherohorinos, 2011). An emblematic obesogen
is the pesticide active ingredient dichlorodiphenyltrichloro-
ethane (DDT), which is widely used to control mosquito popula-
tions. Although DDT was subsequently banned in the 1970s in
most countries due to its carcinogenic and reproductive toxicity
in humans, DDT is very persistent and its residues continue to
this day to be associated to increased adiposity in humans and
rodents (Cano-Sancho et al., 2017).
The most widely used pesticides around the world are
glyphosate-based herbicides (Benbrook, 2016). Many studies have
investigated toxic effects of glyphosate-based herbicides includ-
ing the possible endocrine disrupting properties of their ingre-
dients (Mesnage et al., 2015, 2017). The reliance on a single
herbicide in glyphosate-tolerant genetically modified (GM) crop-
ping systems has increased the spread of glyphosate-resistant
weeds (Heap and Duke, 2018), which has forced farmers to resort
to using mixtures of glyphosate and additional pesticide active
ingredients (Myers et al., 2016). They include 2, 4-dichlorophe-
noxyacetic acid (2, 4-D), dicamba, mesotrione, isoxaflutole and
quizalofop-p-ethyl (QpE) (Figure 1). Moreover, the agricultural bio-
technology industry has developed GM crops tolerant to multiple
herbicides, including glyphosate, to control resistant weeds
(Myers et al., 2016). It could thus be expected that this change in
agricultural practices will lead to an increased human exposure
to these compounds. Given the alarming global rate of obesity
and the increasing use of pesticides in agriculture, there is an ur-
gent need to evaluate their adipogenic potential.
We describe here the evaluation of the adipogenic potential of
glyphosate, 2, 4-D, dicamba, mesotrione, isoxaflutole, and QpE in
the murine 3T3-L1 preadipocyte lipid accumulation assay sys-
tem. The use of 3T3-L1 cells is a well-established in vitro system
for the investigation of adipogenesis and lipid metabolism with
many studies conducted to validate its use as an adipocyte model
system (Kassotis et al., 2017; Morrison and McGee, 2015). We
found that QpE is a potent inducer of adipogenesis in this 3T3-L1
cell assay. Isoxaflutole and dicamba also caused lipid accumula-
tion but to a lesser degree. Further evaluation of the adipogenic
effects of QpE by testing its metabolites and a commercial formu-
lation, as well as its mechanisms of action in a variety of bioas-
says including an RNA-seq analysis, suggested that this
compound exerts its effects in part via a peroxisome proliferator-
activated receptor gamma (PPARc)-mediated pathway.
MATERIALS ANDMETHODS
Reagents. All reagents and chemicals, unless otherwise
specified, were of analytical grade and were purchased from
Sigma-Aldrich (Gillingham, Dorset, UK). The pesticide active
principles were N-(phosphonomethyl)glycine (glyphosate; CAS:
1071-83-6, XLogP3-AA ¼ 4.6, purity  96%, catalog No.: 337757),
2, 4-D (CAS: 94-95-7, XLogP3-AA ¼ 2.8, purity  97%, catalog No.:
D70724), 3, 6-dichloro-2-methoxybenzoic acid (dicamba; CAS:
1918-00-9, XLogP3-AA ¼ 2.2, purity  98%, Santa Cruz
Biotechnology catalog No.: sc-239692), QpE (CAS: 100646-51-3,
XLogP3-AA ¼ 4.3, purity  98%, Santa Cruz Biotechnology, cata-
log No.: sc-224246), isoxaflutole (CAS: 141112-29-0, XLogP3-AA ¼
2.4, purity  98%, Santa Cruz Biotechnology, catalog No. : sc-
228380), mesotrione (CAS: 104206-82-8, XLogP3-AA ¼ 0.7, purity
> 99%, Santa Cruz Biotechnology, catalog No.: sc-224051), quiza-
lofop acid (CAS: 76578-12-6, XLogP3-AA ¼ 3.6, purity  99.5%,
ChemService Inc, Milford, NH, catalog No.: MET-13174A-50MG),
propaquizafop (CAS: 111479-05-1, XLogP3-AA ¼ 4.6, catalog No.:
31572), tetrahydrofurfuryl alcohol (CAS: 97-99-4, XLogP3-AA ¼
0.1, purity  99%, catalog No.: 185396), 2, 3-dihydroxyquinoxa-
line (CAS: 15804-19-0, XLogP3-AA ¼ 0.2, purity  98%, catalog
No.: 144789), dexamethasone (CAS: 50-02-2, XLogP3-AA ¼ 1.9,
purity  98%, catalog No.: sc-29059). The QpE commercial for-
mulation tested was Targa Super (Nissan Chemical Europe
S.A.R.L, France, which contained 50 g/l QpE, below 5% of calcium
dodecylbenzene sulfonate, below 25% of ethoxylated lauryl al-
cohol C12, below 75% solvent naphtha (petroleum) and super
heavy aromatic (<1% naphthalene); homologation F11-5-004),
Figure 1. Molecular structures of the different pesticide active ingredients tested
in this study in comparison to the positive control dexamethasone.
BISERNI ET AL. | 453
fulvestrant (ICI 182, 780; CAS: 129453-61-8, purity >98%), mifep-
ristone (RU-486; CAS: 84371-65-3, purity 98%). Stock solutions
of glyphosate was prepared in serum-free medium and adjusted
to pH 7.2. Stock solutions of all other compounds were prepared
in dimethyl sulfoxide (DMSO). Dilutions of these stock solutions
to be administered to cell cultures always resulted in a DMSO
concentration below 0.5%.
Cell culture. The murine fibroblast 3T3-L1 cell line was pur-
chased from ZenBio (Cambridge Bioscience, Cambridge, UK)
and was not used past passage 10. Undifferentiated 3T3-L1
cells were grown at 37C (5% CO2) in 75 cm2 flasks (Corning,
Tewksbury) in a maintenance medium composed of phenol
red free Dulbecco’s Modified Eagle Medium (DMEM) (Life
Technologies, Warrington, UK), 10% newborn calf serum
(New Zealand origin, Thermo Fisher Scientific [Life
Technologies]), 2 mM glutamine (GE Healthcare Life Sciences,
Fisher Scientific, Loughborough, UK) and 10 mg/ml penicillin/
streptomycin (Life Technologies). Cells were released from
the flask substratum using 0.05% trypsin-EDTA (Life
Technologies) and counted using a hemocytometer prior to
seeding.
Adipocyte differentiation. For differentiation of murine 3T3-L1 cul-
tures to adipocytes, cells were seeded into 96-well plates
(Dutscher Scientific, Brentwood, UK) at a density of 20 000 cells
per well in 100 ml maintenance medium. Following a 2-day sta-
bilization period, they were switched to differentiation medium
consisting of DMEM, 2 mM glutamine, 10 mg/ml penicillin/strep-
tomycin, 10% fetal bovine calf serum (GE Healthcare Life
Sciences, Buckinghamshire, UK), 500 lM 3-isobutyl-1-methyl-
xanthine (Sigma-Aldrich Ltd) and 100 nM insulin from bovine
pancreas (Sigma-Aldrich Ltd). After a further 2 days of culture,
the medium was refreshed to start the incubation with various
concentrations of the test substances. Dexamethasone was
used as a positive control. Media were replenished every 2 days
for a further 6 days. Lipid accumulation was visualized on day
8 using fluorescent Nile Red staining in accordance with the
manufacturer’s instructions (AdipoRed Assay Reagent, Lonza
Walkersville Inc, USA) and quantified using a microplate reader
(GloMax Multi Microplate Multimode Reader, Promega,
Madison). The fluorescence was measured with a filter giving
an excitation at 490 nm and emission at 510–570 nm. The adipo-
genic effect was expressed as a fold change in emission signal
intensity between untreated differentiated and treated differen-
tiated 3T3-L1 cells.
Cell viability assay. Cell viability was assessed using a colori-
metric 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium
bromide (MTT) assay, which indirectly measures cell number
by testing for activity of mitochondrial succinate dehydroge-
nase. The MTT assay has also been proven to be a reliable
measure of toxicity (Mosmann, 1983). The 3T3-L1 cells were
seeded into 96-well plates (Dutscher Scientific) and differenti-
ated as described above for 8 days with the indicated treat-
ments. The MTT assay was performed as follows. Cells were
incubated with 100 ml of MTT solution (1 mg/ml) for 2 h and
the test terminated by lysing the cells by adding 100 ml DMSO.
As a measure of cell number, the optical density of the cell ly-
sate was determined at 570 nm using a GloMax Multi
Microplate Multimode Reader (Promega). The number of cells
was directly proportional to the intensity of the signal. Cell vi-
ability was expressed as a percentage of the control, untreated
samples.
PPARc transactivation assay. The PPARc assay kit was obtained
from INDIGO Biosciences (Bertin Bioreagent, Montigny le
Bretonneux, France). QpE was tested in this assay in compari-
son to the positive control compound rosiglitazone in a 96-well
plate assay following the manufacturer’s instructions. This as-
say utilizes a nonhuman cell line engineered to constitutively
express human PPARc and also harbor a luciferase reporter
gene under control of a PPARc-responsive promoter.
Compounds that bind to and activate the human PPARc lead to
a proportional increase in luciferase reporter gene expression.
This provides a quantitative and functional measurement of
PPARc activity when cells are treated with either agonists or
antagonists of human PPARc.
Intracellular lipid staining. The 3T3-L1 cells were seeded into 96-
well clear bottom black tissue culture treated plates (Corning)
and differentiated as described above for 8 days with the indi-
cated treatments. Medium was then removed and cells fixed by
addition of 100 ll 4% paraformaldehyde (Thermo Fisher
Scientific). Cells were then stained for intracellular lipid accu-
mulation by adding 50 ll of 1 mg/ml Nile Red (Yorlab, York, UK)
and 1 mg/ml 4’,6-diamidino-2-phenylindole (DAPI) (Santa Cruz
Biotechnology) in 0.2% Triton X-100-phosphate-buffered saline
for 15 min in the dark (Boucher et al., 2015). Nile Red staining for
lipid droplets and DAPI staining for cell nuclei were imaged at
530 and 405 nm, respectively, using fluorescence imaging on a
Nikon Eclipse Ts2 microscope (40 objective).
RNA extraction and library preparation. Independent cultures of
3T3-L1 cells, either treated or untreated with 50 lM QpE, were
harvested and total RNA extracted at 6, 24, and 288 h (12 days)
posttreatment. A total of 5 biological replicates, each in tripli-
cate, were performed (n ¼ 5). RNA extraction was performed us-
ing the Qiagen RNeasy kit (Qiagen, Manchester, UK) according
to the manufacturer’s instructions. RNA samples were assessed
for quantity and integrity using the NanoDrop 8000 spectropho-
tometer V2.0 (ThermoScientific, USA) and Agilent 2100
Bioanalyser (Agilent Technologies, Waldbronn, Germany), re-
spectively. All samples displayed a RIN score of 10 and were
taken forward for RNA library preparation.
Library generation and RNA sequencing. A 100 ng aliquot of total
RNA from each sample was used to prepare mRNA libraries us-
ing the NEBNext mRNA isolation kit in conjunction with the
NEBNext Ultra II Directional RNA Library preparation kit (New
England Biolabs, Massachusetts), and samples randomized be-
fore preparation. Fragmentation of isolated mRNA prior to first
strand cDNA synthesis was conducted using incubation condi-
tions recommended by the manufacturer for a fragment size of
300 bp (94C for 10 min). A total of 13 cycles of PCR were per-
formed for final library amplification. Resulting libraries were
quantified using the Qubit 2.0 spectrophotometer (Life
Technologies, California) and average fragment size assessed
using the Agilent 2200 Tapestation (Agilent Technologies). A fi-
nal sequencing pool was created using equimolar quantities of
each sample with compatible indexes. Paired-end reads of 75 bp
were generated for each library using the Illumina NextSeq500
in conjunction with the NextSeq500 v2 High-output 150-cycle
kit (Illumina Inc., Cambridge, UK).
Statistical analysis. The statistical analysis of the dose-response
results from the adipogenesis assay was performed by ANOVA.
Pair-wise comparisons were made using a Mann-Whitney test.
Nonlinear regression analysis was performed using 5-
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parameter logistic dose-response curve models. These statisti-
cal analyses were performed using GraphPad Prism version 7.00
for MAC OS X (GraphPad Software, La Jolla, California, www.
graphpad.com). The analysis of the RNA-seq data was per-
formed using the new version of the Tuxedo protocol with
HISAT2, StringTie and Ballgown as previously described
(Mesnage et al., 2018a). Briefly, sequences were aligned to the
mouse genome 91, GRCm38, using the program HISAT2. Then,
transcripts were assembled and quantified using the program
StringTie. Differential gene analysis was conducted using
Ballgown, in R environment (R Core Team, 2017). We identified
statistically significant increases or decreases in gene expres-
sion with a minimum fold change of 1.2 and a p-value < .05. The
gene set enrichment analysis was performed using Enrichr web
servers (Kuleshov et al., 2016). These RNA-seq data have been
submitted to Gene Omnibus and are accessible through acces-
sion number GSE121419.
RESULTS
The aim of this study was to investigate the adipogenic poten-
tial of major chemicals declared as active principles in commer-
cial herbicide formulations. The adipogenic assay employed
involves looking for lipid accumulation in response to test sub-
stances in murine 3T3-L1 cells, which had been induced to un-
dergo differentiation to adipocytes. Using dexamethasone as a
positive control shows this to be a sensitive assay system caus-
ing a maximum 21-fold increase in lipid accumulation by com-
parison to untreated differentiated cells (Figure 2). The dose
response of dexamethasone was used to determine the concen-
tration that caused a half-maximal response (EC50), using non-
linear dose-response relationships. The EC50 for
dexamethasone was 9.4 pM. Some of the tested compounds
showed an effect on lipid accumulation with different dose-
response patterns. Treatment with glyphosate, mesotrione and
2, 4-D scored negative. Some of the tested concentrations for
these compounds were statistically significant, but there was
no clear dose-response relationship, which indicates that these
effects are probably random outcomes. The active ingredient di-
camba caused an approximately 2.5-fold increase (p < .001) in
lipid accumulation from a concentration of 500 mM. Isoxaflutole
caused adipogenesis at 50 (p < .01) and 100 mM (p < .001) result-
ing in a 2-fold increase in lipid accumulation (Figure 2). We
found that the active ingredient with the greatest adipogenic
potency was QpE, which gave increases in lipid accumulation
starting at 1 mM, becoming statistically significant at 5 mM (p <
.05) and reaching a 3-fold maximal increase at 50 and 100 mM (p
< .001) (Figure 2). The EC50 determined by nonlinear regression
analysis was 8.8 mM for QpE. The adipogenic effect of QpE was
further confirmed by Nile Red lipid staining (Figure 3). The 3T3-
L1 cells treated with 1 mM QpE for 8 days showed a clear increase
in lipid accumulation as was observed with cells treated with
dexamethasone (0.05 nM). We thus decided to focus further
investigations on the mode of action of QpE.
It is important to note that QpE undergoes rapid metabolism
upon ingestion (European Food Safety Authority, 2009).
Therefore, 3 metabolites of QpE (quizalofop acid, tetrahydrofur-
furyl alcohol, and 2, 3-dihydroxyquinoxaline) and another ac-
tive principle from the same class of pesticides (propaquizafop),
were tested in the 3T3-L1 cell lipid accumulation assay. Neither
the QpE metabolites nor propaquizafop were able to induce lipid
accumulation in 3T3-L1 preadipocytes (Figure 2). A commercial
formulation of QpE (Targa Super) also appeared to cause an in-
crease in lipid accumulation albeit at the highest concentrations
tested of 500 and 1000 mM. However, this appears to be an arti-
fact due to the pesticide coformulants since we observed an in-
crease in fluorescence intensity in the absence of cells
(Supplementary Figure 1). We then compared the toxicity of
these chemicals using an MTT viability assay. The results
showed that the QpE commercial formulation was approxi-
mately 1000 times more toxic than its active principle (Figure 4).
In addition, we found that the metabolite quizalofop acid was
approximately 10-times more toxic than its parent compound
QpE (Supplementary Figure 2).
Pesticides are often applied as a mixture in a simultaneous
or sequential manner during crop cultivation, or found as mix-
tures in the environment, making the combined effects of active
principles an important question. We therefore next tested QpE
in combination with 10 mM of glyphosate, 2, 4 D, dicamba, meso-
trione, and isoxaflutole to determine if they were able to poten-
tiate the adipogenic effect of QpE. No additive effects of these
active ingredients on QpE action were observed under any of
the mixture conditions (Supplementary Figure 3).
We next conducted a transcriptome analysis of QpE-exposed
3T3-L1 cells in an effort to obtain mechanic insight into the adi-
pogenic capability of this compound through differential gene
expression analysis. RNA-seq was conducted on the Illumina
sequencing platform with samples from 3T3-L1 cells either
treated or untreated with 50 lM QpE. Cells were harvested and
RNA extracted at 6, 24, and 288 h (12 days) following treatment.
Initially, a principal component analysis (PCA) was conducted
on the FPKM (Fragments Per Kilobase Million) values (Figure 5).
The first 2 components accounted for 25% of the total variability
in our data, which was mainly driven by the separation between
the different time point groups. However, there was also a clear
separation between the treatment groups showing that QpE
had a significant effect on the gene expression profile of the
3T3-L1 cells (Figure 5). We used the Enrichr gene set enrichment
analysis web server to investigate pathway over-representation
in the gene expression alterations caused by QpE (Table 1) in
conjunction with the pathway databases Kyoto Encyclopedia of
Genes and Genomes (KEGG), Wikipathways, and Reactome. No
pathways were found to be significantly disturbed after 6 h of
treatment as indicated. Contrastingly, there was a statistically
significant enrichment of adipogenesis pathways after 24
h treatment. In particular the enrichment of the pathway
“Nuclear receptors in lipid metabolism and toxicity” was a clear
confirmation that QpE had an adipogenic effect. Although this
doesn’t directly provide information on the modulators of gene
expression involved in the observed adipogenesis process, this
result suggests that the effects of QpE could be mediated by a
nuclear receptor whose modulation influences lipid metabo-
lism. The pathway enrichment analysis of the transcriptome
profile alterations caused by a 12-day exposure to QpE mostly
reflected the consequence of the lipid accumulation. The most
altered metabolic pathways reflected mitochondrial functional
disturbances. The most significantly altered pathway was that
for nonalcoholic fatty liver disease. Then, we attempted to iden-
tify the receptor mediating QpE adipogenic effects by analyzing
the overrepresentation of transcription factor binding sites in
the promoters of the genes having their expression altered by
QpE (Supplementary Figure 4). The transcription factor, which
was likely to bind to the genes whose expression was altered af-
ter 6 h QpE exposure was the upstream stimulatory factor-2,
which is a known modulator of lipid metabolism, but which
does not provide a mechanism of action for QpE. The genes
with altered expression highlighted by the transcriptome pro-
files after 24 h and 12 days exposure were enriched in PPARc
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binding sites. However, key adipogenic genes such as Fabp4, Lpl,
and Adipoq did not have their levels altered by QpE.
As PPARc activation is known to be a master regulator of adi-
pogenesis (Kershaw et al., 2007; Shao et al., 2016), we then con-
ducted a series of experiments to further investigate the mode
of action of QpE. Neither the estrogen receptor antagonist ICI
182, 780 nor the glucocorticoid receptor antagonist RU486 was
able to block QpE-mediated lipid accumulation (Figure 6A). We
also tested the ability of QpE to bind and activate PPARc in a lu-
ciferase reporter gene assay. The basis of this commercially
available system is a double-transgenic cell line, which consti-
tutively expresses human PPARc and harbors a luciferase re-
porter gene driven by a PPARc-responsive promoter. Thus, in
the presence of PPARc agonists an increase in luciferase gene
expression will be observed. Treatment with the positive con-
trol substance rosiglitazone gave a maximum stimulation of ap-
proximately 50-fold at 1 lM concentration (Figure 6B). QpE also
resulted in a modest but consistent increase in luciferase ex-
pression of approximately 2-fold at 100 lM, which is albeit only
4% of the maximal response caused by rosiglitazone. This sug-
gests that the QpE activation of PPARc is only in part a
contributory mechanism to the lipid accumulation capability
displayed by this compound (Figure 6B).
DISCUSSION
The global epidemic of obesity is multifactorial in origin and
includes exposure to chemicals acting as endocrine disruptors.
We have tested for the first time commonly used herbicide ac-
tive principles in an adipogenesis assay to evaluate their obeso-
genic potential. Using the 3T3-L1 cell assay system, which
scores for lipid accumulation following differentiation to adipo-
cytes, isoxaflutole and dicamba were found to be adipogenic at
high concentrations only, whilst glyphosate and mesotrione
scored negative at all concentrations tested. Contrastingly, we
found that QpE was a potent and efficient inducer of increased
lipid accumulation in 3T3-L1 adipocytes (Figs. 2 and 3).
Transcriptomics analysis revealed that QpE possesses the pro-
file of a PPAR-c agonist (Table 1; Supplementary Figure 4). The
potential for QpE to activate PPAR-c was suggested in a lucifer-
ase reporter gene assay (Figure 6B). However, PPAR-c activation
occurred at QpE concentrations 100-times higher than those
Figure 2. QpE induces lipid accumulation in 3T3-L1 adipocytes. Cells of the 3T3-L1 line, which had been induced to undergo differentiation to adipocytes, were treated
with several pesticide active ingredients and 0.05 mM dexamethasone (Dex), which acted as a positive control. QpE metabolites, propaquizafop and a commercial QpE
herbicide formulation (Targa Super) were also tested. Note that the effects of the QpE formulation are an artifact due to the pesticide co-formulants since we observed
an increase in fluorescence intensity in the absence of cells (Supplementary Figure 1). After 8 days of treatment with the indicated compounds, lipid accumulation was
evaluated by measuring fluorescence intensity following Nile Red staining. Results are expressed as fluorescence intensity relative to the treatment-free control cells.
Data are the mean 6 SE of at least 5 independent experiments, with each performed in triplicate (*p < .05; **p < .01; ***p < .001). Nonlinear regression analysis was per-
formed for dexamethasone and QpE using the Hill equation, as they were the only compounds to show a dose response of sufficient quality to obtain convergence of a
nonlinear model.
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which induced lipid accumulation, and reached only 4% of the
maximal response caused by the potent agonist rosiglitazone.
This suggests that the adipogenic effect of QpE in 3T3-L1 cells is
only partially accountable by PPAR-c activation.
Further research is required to understand the molecular
mechanisms by which QpE causes lipid accumulation. It is
likely that QpE acts on the PPAR-c pathway independently of
the activation of the receptor. In support of this possibility is the
recently reported observation that the fungicide active ingredi-
ent pyraclostrobin caused lipid accumulation by inducing mito-
chondrial dysfunction independent of PPARc activation (Luz
et al., 2018).
The liver has been proposed to be the main target of toxicity
for QpE in studies conducted for regulatory purposes (European
Food Safety Authority, 2009). The administration of 3.7 mg/kg
bw/day QpE to laboratory rats increased the number of liver
masses and centrilobular enlargement of this organ in both
sexes (EPA, 2016). Few peer-reviewed studies are available, but a
case report has confirmed that commercial formulations of pes-
ticides containing QpE can also be a probable inducer of chole-
static/hepatocellular liver injury in human (Elefsiniotis et al.,
2007). Hepatic cholestasis can be accompanied by fatty changes
(Ju¨ngst et al., 2013), and it is likely that the mechanisms of action
Figure 3. The adipogenic effect of QpE confirmed using fluorescence imaging. The 3T3-L1 adipocyte cells were cultured with standard treatment-free medium (control),
or in the presence of 1 mM QpE or 0.05 nM dexamethasone (positive control). After 8 days of differentiation with the indicated treatments, lipid accumulation was visu-
alized by fluorescent Nile Red staining and the cells visualized by fluorescence microscopy. Nile Red staining for lipid droplets and DAPI staining for cell nuclei were im-
aged at 530 and 405 nm, respectively, using fluorescence imaging on a Nikon Eclipse Ts2 microscope (40 objective).
Figure 4. Viability of 3T3-L1 adipocytes exposed to QpE and its commercial for-
mulation Targa Super. The 3T3-L1 adipocyte differentiated cells were treated
with QpE and Targa Super (0.1–1000 mM). The quantity of formulated
Targa Super is expressed as QpE equivalent concentrations. After 8 days of dif-
ferentiation with the indicated treatments, cell viability was determined by
an MTT colorimetric assay. Results are expressed as cell viability percentage rel-
ative to the viability cell count under treatment-free conditions. Data are the
mean 6 SE of 3 independent experiments, with each performed in triplicate (***p
< .001).
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Figure 5. RNA-seq reveals alterations of adipocyte transcriptome profiles by QpE. PCA of the 3T3-L1 cell transcriptome following exposure to 50 lM QpE for 6, 24, and
288 h (12 days) compared with untreated control cultures (NC).
Table 1. Pathway Enrichment Analysis of the Transcriptome of 3T3-L1 Cells Exposed to QpE Shows Lipid Metabolism Dysregulation Associated
With Markers of Nuclear Receptor Activation
Source pathway_name p Adj-p
6 h
WP Exercise-induced Circadian Regulation_Mus musculus_WP544 2.8E-03 2.3E-01
Diurnally Regulated Genes with Circadian Orthologs_Mus musculus_WP1268 3.2E-02 5.6E-01
G Protein Signaling Pathways_Mus musculus_WP232 9.4E-02 5.6E-01
Fatty Acid Biosynthesis_Mus musculus_WP336 1.2E-01 5.6E-01
Signal Transduction of S1P Receptor_Mus musculus_WP57 1.2E-01 5.6E-01
KEGG Fanconi anemia pathway_hsa03460 3.7E-03 3.4E-01
Circadian rhythm_hsa04710 1.3E-02 6.2E-01
Toxoplasmosis_hsa05145 3.2E-02 6.2E-01
Rap1 signaling pathway_hsa04015 3.6E-02 6.2E-01
Spliceosome_hsa03040 4.4E-02 6.2E-01
24 h
WP Adipogenesis genes_Mus musculus_WP447 1.8E-05 2.6E-03
Nuclear receptors in lipid metabolism and toxicity_Mus musculus_WP431 1.8E-03 9.3E-02
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway_Mus musculus_WP2841 8.1E-03 1.6E-01
miRNA regulation of DNA Damage Response_Mus musculus_WP2087 5.5E-03 1.5E-01
p53 signaling_Mus musculus_WP2902 5.5E-03 1.5E-01
KEGG Malaria_Homo sapiens_hsa05144 2.2E-04 4.6E-02
Proteoglycans in cancer_hsa05205 1.0E-03 1.1E-01
MAPK signaling pathway_hsa04010 2.1E-03 1.4E-01
Cytokine-cytokine receptor interaction_hsa04060 7.9E-03 3.0E-01
Melanoma_hsa05218 8.5E-03 3.0E-01
228 h
WP Electron Transport Chain_Mus musculus_WP295 2.3E-10 4.0E-08
Proteasome Degradation_Mus musculus_WP519 6.7E-09 7.6E-07
PodNet: protein–protein interactions in the podocyte_Mus musculus_WP2310 2.5E-05 1.1E-03
Adipogenesis genes_Mus musculus_WP447 1.0E-05 5.7E-04
Oxidative phosphorylation_Mus musculus_WP1248 3.1E-05 1.2E-03
KEGG Nonalcoholic fatty liver disease (NAFLD_hsa04932 7.0E-11 1.8E-08
Parkinson’s disease _hsa05012 3.0E-10 3.8E-08
Alzheimer’s disease _hsa05010 1.2E-09 8.1E-08
Oxidative phosphorylation_hsa00190 1.3E-09 8.1E-08
Huntington’s disease_hsa05016 1.2E-08 6.0E-07
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of QpE-induced lipid accumulation in our study can be related
to a role of QpE as a probable inducer of occupational liver in-
jury. HepaRG human liver cells have been described as a reliable
model to understand the mechanism of toxicant-induced stea-
tosis such as for lipid uptake, lipid efflux, fatty acid oxidation,
and lipid accumulation (Angrish et al., 2017). We recently
showed that QpE caused alterations in gene expression that are
associated with changes in fatty acid degradation and response
to alcoholism in HepaRG cells (Mesnage et al., 2018b).
Our study indicated that QpE but not his metabolites in-
duced lipid accumulation in 3T3-L1 adipocytes. Quizalofop her-
bicides show a relatively rapid absorption and distribution, and
rather slow elimination in urine and feces with only 56%–70% of
QpE being eliminated after administration to rats (European
Food Safety Authority, 2009). Upon ingestion, it is rapidly me-
tabolized in quizalofop acid, followed by hydroxylation. Only
quizalofop acid but not QpE was detected after the administra-
tion of 10 mg/kg QpE in rats (Liang et al., 2014). It is interesting to
note that QpE can be found as 2 different enantiomers poten-
tially having different toxicological properties. For instance,
R(þ)-forms of aryloxypropanoates are more potent acetyl coen-
zyme A carboxylase inhibitors and thus have higher herbicidal
activities (Kurihara et al., 1997). In a toxicokinetic study in rats,
the concentrations of R(þ)-quizalofop-acid exceeded those of
R()-quizalofop-acid (Liang et al., 2014). Only the R(þ) enantiom-
ers of quizalofop were present in large excess in rat body fluids.
The differential toxicity of the different forms of quizalofop is
unclear. However, a recent study investigating the toxicity of
QpE and its metabolite quizalofop acid on the worm Eisenia foe-
tida found that the metabolite was far more toxic than the par-
ent compounds (Ma et al., 2016). The same study also showed
QpE and quizalofop acid enantioselective toxicity to these
earthworms, with the racemic mixtures being more toxic than
the R(þ) forms alone (Ma et al., 2016).
We have also compared the toxicity of glyphosate, QpE, mes-
otrione, and isoxaflutole on HepaRG human liver cells (Mesnage
et al., 2018b). The differences in toxicity between these com-
pounds were similar to what we found in this study. QpE was
the most toxic and affected the expression of genes involved in
lipid metabolism (Mesnage et al., 2018b). Isoxaflutole was less
toxic to HepaRG cells but caused alterations in gene expression
profiles correlated with activation of nuclear receptors such as
the pregnane X receptor and PPAR-c. By comparison, glyphosate
and mesotrione caused only few and subtle changes, as ob-
served here.
Our study uses the well-established murine 3T3-L1 cell line
model system for obesogenic screening. However, this cell line
can only address a limited number of possible modes of ac-
tion. The 3T3-L1 cells consist of unipotent preadipocytes,
which can only differentiate into mature adipocytes.
Mesenchymal stem cells may constitute a suitable alternative
model system due to their multipotent nature and which can
also be used to study earlier stages of the adipocyte differenti-
ation pathway (Kirchner et al. 2010). Another important limita-
tion of 3T3-L1 cells that needs to be born in mind is that they
are of murine origin, and may not fully be representative of
human metabolism. In addition, stocks of 3T3-L1 cells from
different sources can have different metabolic capabilities
(Kassotis et al., 2017). A recent comparison of different proto-
cols and cell lines used in adipogenesis assays revealed that
cell source (ATCC vs Zenbio 3T3-L1) and culture protocols have
a significant impact on the results of this assay (Kassotis
et al., 2017).
The commercial formulated product Targa Super, containing
QpE as an active ingredient, failed to induce adipogenicity
(Figure 2). This appears to be due to the fact that we found
Targa Super to be approximately 1000 times more toxic than
QpE itself. This does not come as a surprise since this pesticide
formulation contained naphtha (petroleum) solvent and super
heavy aromatic compounds (<1% naphthalene). However, it is
still surprising that the authors of scientific studies keep con-
founding the declared active principles of a pesticide with the
pesticide itself (Mesnage and Antoniou, 2017). For example, the
report describing liver injury induced by the spraying of a QpE-
based formulation refers to QpE as a herbicide, and does not dis-
cuss the composition of the pesticide sprayed by the subject of
this case study (Elefsiniotis et al., 2007). Thus, it is not possible
to be certain that the effects described in this report are due to
QpE itself or to a coformulant in the commercial preparation, or
combination of the 2, making the conclusion of the authors
Figure 6. QpE effects on nuclear receptors. A, The 3T3-L1 adipocyte differentiated cells were treated with Dex (10 nM) and QpE (quiz, 100 mM) in the presence or absence
of either 1 mM ICI 182, 780 or RU486. B, PPARc assay using a luciferase reporter gene system shows a consistent but modest increase in expression by QpE in comparison
to rosiglitazone. (Note: different scales in the y-axis). Note: cells treated with 17b-estradiol alone did not cause any lipid accumulation, the results of which in the inter-
ests of clarity of presentation are not shown.
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unsubstantiated. Other commercial formulations of QpE, or of
other pesticide ingredients, may have different effects because
they contain different mixtures of coformulants, some of which
have been showed to cause adipogenic effects (Kassotis et al.,
2018).
In conclusion, we reveal alterations of adipocyte metabolism
by major pesticide active ingredients. In particular, we found
that QpE was a potent stimulator of lipid accumulation and
thus potentially a hitherto unsuspected obsogen. QpE is pro-
moted as a new selective postemergence herbicide to control
weeds resistant to glyphosate, and thus its agricultural use is
expected to increase in coming years. Although our results can-
not be readily translated to policy recommendations, it is clear
from the study presented here and work conducted by others
that a proper comparative risk-benefit analysis should be per-
formed when new pesticide active ingredients are promoted as
substitutes.
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